article thumbnail

How Marketing Still Needs Racial Redemption

Mindful Marketing

During a time focused on re-opening the economy after the onset of a viral pandemic, there are glaring signs that the United States is suffering from another type of pandemic—racism. These assumptions also ignore research evidence which indicates inherent (automated) bias in AI technology.

article thumbnail

The Most Recommended PR Tech Vendors [PR Tech Sum]

Sword and the Script

That’s a mouthful of buzzwords, but Ryan Reeves, a product manager for the company, added some context on LinkedIn: “Signals uses AI to continually read trillions of articles to detect important company trigger-events (viral articles, product launches, financials, partnerships, headcount changes, etc.)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

10 Types of Content That Drive Demand & Boost Engagement

Cision

PhRMA, the Pharmaceutical Research, and Manufactures of America faced this exact challenge. Their finger-stopping content went viral – earning over 500 global media placements culminated with over 300 million impressions. The influx of technology and the data it yields makes everyone a researcher. Surveys & Research.

article thumbnail

10 Types of Content That Drive Demand & Boost Engagement

Beyond PR

PhRMA, the Pharmaceutical Research, and Manufactures of America faced this exact challenge. Their finger-stopping content went viral – earning over 500 global media placements culminated with over 300 million impressions. The influx of technology and the data it yields makes everyone a researcher. Surveys & Research.

article thumbnail

The Biggest PR Disasters Of 2016

ImPRessions - Crenshaw Communications

The story of a new blood-testing technology for clinical tests that needed only a single drop of blood was irresistible to media, and founder Elizabeth Holmes was a PR dream. Heather Bresch, CEO of pharmaceutical company Mylan, became the poster child for industry greed in 2016. EpiPen price causes outrage. Move over, Martin Shkreli!

Banking 202